眼眶丛状神经纤维瘤合并腹膜后神经纤维瘤1例报告并文献复习
A Case Report and Literature Review of Orbital Plexiform Neurofibroma Complicated with Retroperitoneal Neurofibroma
DOI: 10.12677/ACM.2023.1371693, PDF, HTML, XML, 下载: 173  浏览: 226 
作者: 张德馨, 周子微:青岛大学医学部,山东 青岛;青岛大学附属医院,山东 青岛;王 谦*:青岛大学附属医院,山东 青岛
关键词: 丛状神经纤维瘤眼眶肿瘤免疫组织化学诊断病例报告Plexiform Neurofibroma (PNF) Orbital Tumors Immunohistochemistry Diagnosis Case Report
摘要: 目的:探讨眼眶丛状神经纤维瘤的临床特征,以加深对该肿瘤的认识。方法:回顾性分析1例眼眶丛状神经纤维瘤患者的临床资料,并结合国内外文献进行复习探讨。结果:患者以发现左眼眼球突出2年为主要临床表现,眼科联合神经外科经颅开眶行眶内及颅内肿瘤切除术,术后病理学检查示肿瘤细胞排列松散,呈纺锤样,组织可见丰富小血管及绳索样的粗大神经,神经纤维束呈波浪状排列。免疫组化染色示S-100阳性、SOX10弱阳性,不表达SMA、EMA、CD34。随访1个月未见肿瘤复发、转移。结论:眼眶丛状神经纤维瘤临床较罕见,具有独特的病理学特征,手术治疗疗效确切。
Abstract: Objective: To investigate the clinical features of plexiform neurofibroma (PNF) to improve under-standing. Methods: The clinical data of a patient with orbital plexiform neurofibroma were retro-spectively described, reviewed and discussed with domestic and international literature. Results: The patient presented with eye tubercle for 2 years as a main clinical manifestation. Ophthalmology combined with neurosurgery performed transcranial orbital and intracranial tumor resection. The tumor cells were loosely arranged and spindle-like, with abundant small blood vessels and rope-like thick nerves visible in the tissues. The nerve fiber bundles were arranged in a wavy pat-tern. Immunohistochemistry showed that the tumor cells were positive for S-100, weakly positive for SOX10, and didn’t express SMA, EMA, CD34. No tumor recurrence or metastasis was observed in the 1-month follow-up after surgery. Conclusion: Orbital plexiform neurofibroma is rare clinically, and has unique clinical pathology features. The efficacy of surgical excision is definite.
文章引用:张德馨, 周子微, 王谦. 眼眶丛状神经纤维瘤合并腹膜后神经纤维瘤1例报告并文献复习[J]. 临床医学进展, 2023, 13(7): 12077-12082. https://doi.org/10.12677/ACM.2023.1371693

参考文献

[1] Ettl, A., Marinkovic, M. and Koornneef, L. (1996) Localized Hypertrichosis Associated with Periorbital Neurofibroma: Clinical Findings and Differential Diagnosis. Ophthalmology, 103, 942-948.
https://doi.org/10.1016/S0161-6420(96)30582-4
[2] Carroll, G.S., Haik, B.G., Fleming, J.C., et al. (1999) Pe-ripheral Nerve Tumors of the Orbit. Radiologic Clinics of North America, 37, 195-202.
https://doi.org/10.1016/S0033-8389(05)70087-7
[3] Bechtold, D. and Hanne, D. (2012) Plexiform Neurofibroma of the Eye Region Occurring in Patients without Neurofibroma Fibromatosis Type 1. Original Investigation, 28, 413-415.
https://doi.org/10.1097/IOP.0b013e3182627ea1
[4] 宋国祥. 眼眶病学[M]. 北京: 人民卫生出版社, 1999: 214-220.
[5] Belakhoua, S.M. and Rodriguez, F.J. (2021) Diagnostic Pathology of Tumors of Peripheral Nerve. Neu-rosurgery, 88, 443-456.
https://doi.org/10.1093/neuros/nyab021
[6] Anderson, J.L. and Gutmann, D.H. (2015) Neurofibromatosis Type 1. In: Handbook of Clinical Neurology, Vol. 132, Elsevier, Amsterdam, 75-86.
https://doi.org/10.1016/B978-0-444-62702-5.00004-4
[7] The Consensus Development Panel (1994) National In-stitutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. Ar-chives of Neurology, 51, 201-207.
https://doi.org/10.1001/archneur.1994.00540140115021
[8] Ly, K.I. and Blakeley, J.O. (2019) The Diagnosis and Management of Neurofibromatosis Type 1. Medical Clinics of North America, 103, 1035-1054.
https://doi.org/10.1016/j.mcna.2019.07.004
[9] Fisher, M.J. and Blakeley, J.O. (2022) Management of Neurofi-bromatosis Type 1-Associated Plexiform Neurofibromas. Neuro-Oncology, 24, 1827-1844.
https://doi.org/10.1093/neuonc/noac146
[10] Abdolrahimzadeh, B., Piraino, D.C., Albanese, G., et al. (2016) Neu-rofibromatosis: An Update of Ophthalmic Characteristics and Applications of Optical Coherence Tomography. Clinical Ophthalmology, 10, 851-860.
https://doi.org/10.2147/OPTH.S102830
[11] Kinori, M., Hodgson, N. and Zeid, J.L. (2018) Ophthalmic Manifes-tations in Neurofibromatosis Type 1. Survey of Ophthalmology, 63, 518-533.
https://doi.org/10.1016/j.survophthal.2017.10.007
[12] Sweeney, A.R., Gupta, D., Keene, C.D., et al. (2017) Or-bital Peripheral Nerve Sheath Tumors. Survey of Ophthalmology, 62, 43-57.
https://doi.org/10.1016/j.survophthal.2016.08.002
[13] Lai, Y.F., Lee, L.C., Chen, Y.H., et al. (2021) Pulsating Proptosis and Heavy Eye Syndrome Precipitated by Neurofibromatosis Type 1: A Case Report. Medicine (Baltimore), 100, e27575.
https://doi.org/10.1097/MD.0000000000027575
[14] Dereköy, S. and Sefali, M. (2000) Plexiform Neurofibroma of the Submandibular Gland. The Journal of Laryngology & Otology, 114, 643-645.
https://doi.org/10.1258/0022215001906390
[15] Bouirig, K. and Cherkaoui, L.O. (2022) Lisch Nodules: An Oph-thalmic Marker of Neurofibromatosis Type 1. The Pan African Medical Journal, 42, Article No. 108.
https://doi.org/10.11604/pamj.2022.42.108.35079
[16] Farma, J.M., Porpiglia, A.S. and Vo, E.T. (2022) Benign Neurogenic Tumors. Surgical Clinics of North America, 102, 679-693.
https://doi.org/10.1016/j.suc.2022.04.007
[17] Stagner, A.M. and Jakobiec, F.A. (2016) Peripheral Nerve Sheath Tumors of the Eyelid Dermis: A Clinicopathologic and Immunohistochemical Analysis. Ophthalmic Plastic & Recon-structive Surgery, 32, 40-45.
https://doi.org/10.1097/IOP.0000000000000424
[18] Rodriguez, F.J., Folpe, A.L., Giannini, C., et al. (2012) Pa-thology of Peripheral Nerve Sheath Tumors: Diagnostic Overview and Update on Selected Diagnostic Problems. Acta Neuropathologica, 123, 295-319.
https://doi.org/10.1007/s00401-012-0954-z
[19] Zhou, H. and Lu, H. (2021) A Solitary Giant Neurofibroma of Inguinal Region: A Case Report. Science Progress, 104.
https://doi.org/10.1177/00368504211004269
[20] Erb, M.H., Uzcategui, N., See, R.F., et al. (2007) Orbitotem-poral Neurofibromatosis: Classification and Treatment. Orbit, 26, 223-228.
https://doi.org/10.1080/01676830600987227
[21] Njoumi, N., Elabsi, M., Attolou, G., et al. (2015) Solitary Preperitoneal Neurofibroma: A Case Report. BMC Research Notes, 8, Article No. 115.
https://doi.org/10.1186/s13104-015-1098-8